ArticleACR open rheumatology2021

Rituximab Versus Mycophenolate in the Treatment of Recalcitrant Connective Tissue Disease-Associated Interstitial Lung Disease.

Lisa Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.